Shin Kwang Khang Selected Research

Shin Kwang Khang Research Topics

9	Neoplasms (Cancer) 02/2019 - 12/2002
2	Glioma (Gliomas) 03/2018 - 12/2006
2	Hemangiopericytoma 12/2016 - 03/2016
2	Glioblastoma (Glioblastoma Multiforme) 07/2013 - 05/2013
2	Neoplasm Metastasis (Metastasis) 04/2011 - 01/2007
1	Ependymoma 02/2019
1	Rare Diseases (Rare Disease) 12/2016
1	Meningioma (Meningiomas) 12/2016
1	Adenocarcinoma of Lung 08/2016
1	Adenocarcinoma 08/2016
1	Germinoma 10/2014
1	Astrocytoma (Pilocytic Astrocytoma) 05/2013
1	Extranodal Extension 04/2011
1	Breast Neoplasms (Breast Cancer) 04/2011
1	Chondrosarcoma 01/2008
1	Chordoma 01/2008
1	Residual Neoplasm 12/2006
1	Brain Neoplasms (Brain Tumor) 12/2006
1	Lymphoma (Lymphomas) 02/2004
1	Opportunistic Infections (Opportunistic Infection) 02/2004
1	Ganglioneuroma 09/2002
1	Lymph Node Tuberculosis (Scrofula) 04/2002

3	Biological ProductsIBA 12/2016 - 01/2008
2	Biomarkers (Surrogate Marker)IBA 03/2018 - 04/2011
2	Messenger RNA (mRNA)IBA 03/2018 - 05/2013
2	Proteins (Proteins, Gene)FDA Link 03/2018 - 05/2013
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2018 - 05/2013
2	Cyclin D1IBA 05/2013 - 04/2011
1	B7-H1 AntigenIBA 02/2019
1	Monoclonal AntibodiesIBA 02/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 02/2019
1	MagnesiumIBA 03/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 03/2018
1	Cyclin-Dependent Kinase Inhibitor p16IBA 08/2016
1	Temozolomide (Temodar)FDA LinkGeneric 07/2013
1	CateninsIBA 05/2013
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2011
1	Phenobarbital (Luminal)FDA Link 04/2011
1	Cadherins (E-Cadherin)IBA 04/2011
1	Hematoxylin (Haematoxylon)IBA 04/2011
1	Hormones (Hormone)IBA 04/2011
1	Fluorouracil (Carac)FDA LinkGeneric 12/2006
1	Etoposide (VP 16)FDA LinkGeneric 12/2006
1	Vincristine (Oncovin)FDA LinkGeneric 12/2006
1	Pharmaceutical PreparationsIBA 12/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2006
1	ChromatinIBA 12/2002
1	GadoliniumIBA 09/2002
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2002
1	Coloring Agents (Dyes)IBA 04/2002

4	Radiotherapy 03/2016 - 12/2006
3	Drug Therapy (Chemotherapy) 10/2014 - 02/2004
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 07/2013
1	Lymph Node Excision (Lymph Node Dissection) 04/2011
1	Combined Modality Therapy 01/2008
1	Chemoradiotherapy 01/2007
1	Adjuvant Chemotherapy 01/2007
1	Combination Drug Therapy (Combination Chemotherapy) 12/2006